Table 7.
EDC | Animal | Sex | Exposure Period | Dosage, Route | Age at Analysis and Brain Region | Effect | Endpoint(s) | Ref. |
---|---|---|---|---|---|---|---|---|
BPA | Rat (S-D) | M/F | E7 to P21 | 0.01, 0.5, 5, 50, 200 mg/kg/d by gavage to dams | P4, P7, P14, P21, P56; Hippocampus | Aromatase protein was increased in a dose-dependent manner by BPA at ages prior to P56 | Aromatase protein | 475 |
PCBs: reconstituted mixture of PCBs 126, 138, 153, 180 | Rat (S-D) | M/F | E15–E19 to dam, then 2 × weekly to dam until pups were P21 | 10 mg/kg/d given to dams sc | E20, P12, P21, P60; Hypothalamus | 5α-reductase 1 mRNA was decreased in females at P21 and in both sexes at P60. 5α-reductase 2 mRNA was increased in females at P60. Aromatase mRNA was increased in males at P21 | mRNA of 5α-reductase1, 5α-reductase 2, aromatase | 566 |
PCBs: Aroclor 1254 | Rat (S-D) | M/F | E15–E19 to dam; neuronal cultures also performed | 25 mg/kg/d given to dams by gavage for in vivo work. In neuronal cultures, 10, 100, 500 μg/mL | E20 hypothalamus (in vivo) or hypothalamic neuronal cultures | In vivo, there were no effects of A1254 on aromatase activity or mRNA, or on 5α-reductase 1 mRNA. 5α-reductase 2 mRNA was increased in females, and AR mRNA was decreased by A1254. In vitro, the two higher doses of A1254 decreased aromatase activity | mRNA of 5α-reductase 1, 5α-reductase 2; aromatase activity | 1132 |
PCB, PCDD, PCDF reconstituted mixture | Rat (S-D) | M/F | P1, P5, P10, P15, and P20 | Gavaged at 1×, 10×, 100×, 100 × concentrations estimated based on human infant exposures from breast milk | P21; hypothalamus, hippocampus, cortex | The 1000 × mixture had significant effects on Comt (reduced in hypothalamus, hippocampus, cortex of males), Cyp1A1 (elevated in males, all regions), Esr1 (decreased in males in hypothalamus and hippocampus) and Dnmt1 (decreased in hypothalamus of males). 100 × mixture increased Comt in cortex of females. Other data were not shown | mRNA of Cyp1A1, Cyp1B1, Cyp2B1, Comt, Esr1, Dnmt1 | 1133 |
Abbreviations: M, male; F, female; sc, subcutaneous; S-D, Sprague-Dawley.